PMID: 9166428Jun 2, 1997Paper

Regulation of interleukin-12 by complement receptor 3 signaling

The Journal of Experimental Medicine
T Marth, B L Kelsall

Abstract

Complement receptor type 3 (CR3, CD11b/CD18) serves as a receptor for a number of endogenous ligands and infectious organisms, and is involved in adhesion and host defense functions. Here, we report that signaling via CR3 plays an important role in regulating production of interleukin-12 (IL-12), a key mediator of cell-mediated immunity (CMI). We demonstrate with a variety of stimuli a dose-dependent, specific downregulation of IL-12 secretion by human monocytes in vitro after exposure to antibodies to CR3 (anti-CD11b and anti-CD18), as well as to the natural CR3 ligands, iC3b, and Histoplasma capsulatum. CR3 antibodies also suppressed interferon-gamma (IFN-gamma) production in cultures of human peripheral blood mononuclear cells (PBMC). We determined that one mechanism by which CR3 antibodies may suppress IL-12 production is by the inhibition of IFN-gamma-induced tyrosine phosphorylation. Finally, in a murine model of IL-12-dependent septic shock, we provide evidence that administration of CR3 antibodies leads to suppression of IL-12 and IFN-gamma in vivo. Our studies thus define a novel role for CR3 in regulating CMI functions via IL-12.

References

Sep 1, 1991·Immunology Today·N R Cooper
Aug 2, 1990·Nature·T A Springer
Sep 1, 1990·Scandinavian Journal of Immunology·T A Springer
Aug 1, 1989·Scandinavian Journal of Immunology·M Patarroyo, M W Makgoba
Jan 1, 1989·Advances in Immunology·T K KishimotoT A Springer
Jan 1, 1987·Annual Review of Medicine·D C Anderson, T A Springer
Dec 1, 1995·The Journal of Experimental Medicine·T KusunokiS D Wright
Apr 1, 1994·The Journal of Experimental Medicine·J ChehimiG Trinchieri
Jan 1, 1996·The Journal of Experimental Medicine·X MaG Trinchieri
Jun 1, 1996·Infection and Immunity·L L JohnsonP C Sayles
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·T T LuJ A Madri
Oct 31, 1996·Annals of the New York Academy of Sciences·B L KelsallW Strober

❮ Previous
Next ❯

Citations

Jun 9, 1999·Annals of Neurology·C L Karp
Oct 30, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Gaëlle Le FriecClaudia Kemper
Aug 5, 2010·Apoptosis : an International Journal on Programmed Cell Death·Dror Mevorach
Sep 5, 2001·Molecular Immunology·Z FishelsonD Mevorach
Dec 31, 2002·Toxicology·Fernando Acevedo, Olof Vesterberg
Jun 29, 2002·Current Opinion in Immunology·Martin F Bachmann, Manfred Kopf
Sep 2, 1998·Current Opinion in Immunology·J LouisP Launois
Mar 21, 1998·Trends in Microbiology·L S Schlesinger
Mar 17, 2001·Microbes and Infection·C L Karp, M Wills-Karp
Mar 17, 2001·Microbes and Infection·X Ma
Jul 12, 2003·Trends in Parasitology·David H McGuinnessRichard J Pleass
Nov 12, 2005·Parasitology·D J Gregory, M Olivier
Jul 21, 2010·Nature Immunology·Bali PulendranSanthakumar Manicassamy
Aug 20, 2010·Nature Immunology·Daniel RicklinJohn D Lambris
Mar 2, 2005·Nature Reviews. Immunology·Pawel Kalinski, Muriel Moser
Nov 18, 2006·Nature Reviews. Immunology·Ricardo T Gazzinelli, Eric Y Denkers
Dec 16, 2006·Nature Reviews. Immunology·Claudia Kemper, John P Atkinson
Feb 26, 2011·Nature Reviews. Immunology·George Hajishengallis, John D Lambris
Dec 13, 2006·Nature Reviews. Microbiology·Jim E CutlerBruce S Klein
Nov 13, 2004·The New England Journal of Medicine·Peter J MannonUNKNOWN Anti-IL-12 Crohn's Disease Study Group
Dec 22, 1998·The Journal of Experimental Medicine·D MevorachK B Elkon
Oct 19, 1999·The Journal of Experimental Medicine·M ArmantM Sarfati
Dec 27, 2007·Viral Immunology·Kara L CummingsYoung S Hahn
May 15, 2002·Microbiology and Immunology·Kazuyoshi KawakamiAtsushi Saito
Apr 16, 2005·Clinical Microbiology Reviews·Martin OlivierGeneviève Forget

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.